China has established a complete pharmaceutical industry chain and has become one of the largest pharmaceutical producers in the world. During 2006-2013, the Chinese pharmaceutical industry has been growing at an average annual growth rate of 22.6%, which far outpaces that in other economies in the world, making China the world's fastest growing pharmaceutical market. China was the world's ninth largest drug market in 2007, and it became the third in 2011, following the US and Japan. However, certain problems do exist in the industry, like small-scale capacity, scattered geographical layout, duplicated production processes, lack of patented domestically-developed pharmaceuticals, and outdated manufacturing technology & management structures, reminding investors to act with caution.
China is the third largest pharmaceutical market in the world, only next to the US and Japan.
Purpose of report & value to clients:
To help customers know more about the market situation of pharmaceutical industry in China.
Purchasers of pharmaceuticals out of China;
Global pharmaceutical producers;
Investors who want to know more about the conditions of China’s pharmaceutical industry;
Relevant government regulations
Mergers & acquisitions cases
Drug pricing reform
China’s pharmaceutical industry has developed rapidly during 2006-2013, attaining a CAGR of over 22% in terms of gross industrial output. China’s pharmaceutical industry is projected to keep developing fast in the following years, making China the second largest market in the world at around 2020.Methodology: